The presence of IgA in tumour sections was confirmed in a small number of tissue sections with a polyclonal anti human IgA reagents (data not shown) There may be different explanations of the enrichment of IgA1 in tumour cells, such as specific binding of the antibody to tumour cells [19] or the active uptake of IgA1. This evidence concerns the gene CD79A and neoplasm.